HOUSTON, TX / ACCESS Newswire / May 13, 2025 / CNS Pharmaceuticals, Inc. (NASDAQ:CNSP) ("CNS" or the "Company"), a biopharmaceutical company specializing in the development of novel treatments for ...

CNS CEO John Climaco stated, "The successful transfer of the Orphan Drug Designations for TPI 287 demonstrates our operational efficiency as well as our ongoing commitment to the development of ...

The biotechs have been working together in the CNS space since a $1.7 billion biobucks pact in 2019, with their relationship strengthened in 2023 to focus on Voyager’s gene therapy program for ...

LG CNS announced Monday that it has signed a 130 billion won ($88.8 million) deal with Mirae Asset Life Insurance to support the insurer’s artificial intelligen ...

The CNS market is expected to exceed $80 billion in sales this year, per GlobalData’s analysis. That would place its year-over-year growth rate at 8%—another high not seen since 2013.

CNS Pharmaceuticals' Berubicin trial results show a favorable safety profile with no cardiotoxicity and comparable efficacy to Lomustine in recurrent GBM.

LG CNS on Wednesday said it is expanding into the North American market with its latest warehouse automation robots. The IT solutions arm of LG Group is participating in ProMat 2025, a major ...

Researchers from Fujita Health University, Japan, observed a rise in adult central nervous system (CNS) infections, primarily aseptic meningitis caused by the varicella zoster virus (VZV), post-2019.

Since 2014, CNS has modernized much of the aging infrastructure at Pantex by executing more than $1.4 billion of projects at the plant. Many of these projects replaced nearly 80-year-old ...

CNS Pharmaceuticals, Inc CNSP shares are trading lower by 33.4% to $0.14 during Monday’s session after the company announced a 1-for-50 reverse split of its common stock, effective at 4:01 PM ET ...

Base- and sugar-modification reduce ASO toxicity in the CNS A novel chemical modification called 2′,4′-BNA/LNA with a 9-(aminoethoxy)phenoxazine (BNAP-AEO) was recently created by researchers ...

CNS metastases negatively affect patient quality of life (QoL) and prognosis 1,2 and are common in patients with epidermal growth factor receptor (EGFR)–mutated advanced non–small-cell lung cancer ...